Based on the data provided, we observe the following year-on-year variations: 2024 (0%), 2025 (0%), 2026 (1.67%), 2027 (0%), 2028 (0%). The last Compound Annual Growth Rate (CAGR) over the five-year period from 2024 to 2028 is approximately 0.33%.
Future trends to watch in the South Korean market for obstructive airway diseases medicine include advancements in personalized medicine, increasing prevalence of chronic respiratory conditions, and potential impacts from demographic shifts such as aging population. Additionally, monitoring regulatory changes and healthcare policies will be crucial in understanding the potential market growth.
